213 related articles for article (PubMed ID: 28816137)
1. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review.
Buckley H; Wilson C; Ajithkumar T
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137
[TBL] [Abstract][Full Text] [Related]
2. High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review.
Cheng T; Peng R; Qu A; Wang H
Cancer Sci; 2023 Nov; 114(11):4145-4156. PubMed ID: 37702196
[TBL] [Abstract][Full Text] [Related]
3. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study.
Rijkmans EC; Cats A; Nout RA; van den Bongard DHJG; Ketelaars M; Buijsen J; Rozema T; Franssen JH; Velema LA; van Triest B; Marijnen CAM
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):908-917. PubMed ID: 28366579
[TBL] [Abstract][Full Text] [Related]
4. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
[TBL] [Abstract][Full Text] [Related]
5. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects.
Nout RA; Devic S; Niazi T; Wyse J; Boutros M; Pelsser V; Vuong T
Brachytherapy; 2016; 15(4):477-484. PubMed ID: 27090225
[TBL] [Abstract][Full Text] [Related]
6. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
7. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
8. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
[TBL] [Abstract][Full Text] [Related]
9. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes.
Lee JH; Kim SH; Kim JG; Cho HM; Shim BY
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):431-8. PubMed ID: 20732756
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
[TBL] [Abstract][Full Text] [Related]
12. Alternative clinical end points in rectal cancer--are we getting closer?
Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
[TBL] [Abstract][Full Text] [Related]
13. High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
Ceelen WP; Van Nieuwenhove Y; Fierens K
Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264
[TBL] [Abstract][Full Text] [Related]
15. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
Ortholan C; Romestaing P; Chapet O; Gerard JP
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
De Caluwé L; Van Nieuwenhove Y; Ceelen WP
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565
[TBL] [Abstract][Full Text] [Related]
17. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.
Rijkmans EC; van Triest B; Nout RA; Kerkhof EM; Buijsen J; Rozema T; Franssen JH; Velema LA; Laman MS; Cats A; Marijnen CAM
Radiother Oncol; 2018 Mar; 126(3):417-423. PubMed ID: 29398154
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer.
Dizdarevic E; Frøstrup Hansen T; Pløen J; Henrik Jensen L; Lindebjerg J; Rafaelsen S; Jakobsen A; Appelt A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):556-563. PubMed ID: 31707122
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study.
Lin JZ; Peng JH; Qdaisat A; Lu ZH; Wu XJ; Chen G; Ding PR; Li LR; Gao YH; Zeng ZF; Wan DS; Pan ZZ
Oncotarget; 2016 Aug; 7(35):57317-57326. PubMed ID: 27374175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
